Summit Therapeutics Inc. SEC filings SMMT
Summit Therapeutics Inc. has 564 filings in SEC EDGAR's recent list, going back to Mar 4, 2014. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Apr 27, 2026 | — |
| CORRESP | Letter to the SEC | Apr 16, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 2, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 21, 2025 | — |
| CORRESP | Letter to the SEC | Jan 6, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2024 | — |
| D | Filing | Sep 26, 2024 | — |
| D | Filing | Jun 18, 2024 | — |
| EFFECT | Filing | Feb 27, 2024 | — |
| CORRESP | Letter to the SEC | Feb 23, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 22, 2024 | — |
| EFFECT | Filing | Apr 27, 2023 | — |
| CORRESP | Letter to the SEC | Apr 25, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2023 | — |
| EFFECT | Filing | Feb 3, 2023 | — |
| CORRESP | Letter to the SEC | Jan 31, 2023 | — |
| CORRESP | Letter to the SEC | Jan 20, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2023 | — |
| CT ORDER | Filing | Apr 14, 2022 | — |
| CT ORDER | Filing | Apr 14, 2022 | — |
| CT ORDER | Filing | Jun 17, 2021 | — |
| EFFECT | Filing | Jan 19, 2021 | — |
| CORRESP | Letter to the SEC | Jan 15, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2021 | — |
| D | Filing | Nov 23, 2020 | — |
| EFFECT | Filing | Oct 15, 2020 | — |
| CORRESP | Letter to the SEC | Oct 13, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 9, 2020 | — |
| 25-NSE | Delisting notice | Sep 18, 2020 | — |
| 8-K12B | Filing | Sep 18, 2020 | Sep 18, 2020 |
| D | Filing | Jan 2, 2020 | — |
| EFFECT | Filing | Jun 20, 2019 | — |
| CORRESP | Letter to the SEC | Jun 18, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2019 | — |
| CT ORDER | Filing | Apr 26, 2019 | — |
| D | Filing | Jan 18, 2019 | — |
| EFFECT | Filing | May 29, 2018 | — |
| CORRESP | Letter to the SEC | May 24, 2018 | — |
| UPLOAD | Letter from the SEC | May 24, 2018 | — |
| CT ORDER | Filing | May 9, 2018 | — |
| CT ORDER | Filing | Jan 3, 2018 | — |
| CT ORDER | Filing | Jan 3, 2018 | — |
| CT ORDER | Filing | Jan 3, 2018 | — |
| CT ORDER | Filing | Jun 22, 2017 | — |
| CT ORDER | Filing | Apr 27, 2017 | — |
| CT ORDER | Filing | Nov 21, 2016 | — |
| EFFECT | Filing | Jun 3, 2016 | — |
| CORRESP | Letter to the SEC | Jun 1, 2016 | — |
| UPLOAD | Letter from the SEC | May 25, 2016 | — |
| CT ORDER | Filing | May 25, 2016 | — |
| CT ORDER | Filing | Mar 9, 2015 | — |
| EFFECT | Filing | Mar 4, 2015 | — |
| EFFECT | Filing | Mar 4, 2015 | — |
| CERTNAS | Auto-generated paper document | Mar 4, 2015 | — |
| 8-A12B | Filing | Mar 2, 2015 | — |
| CORRESP | Letter to the SEC | Mar 2, 2015 | — |
| CORRESP | Letter to the SEC | Mar 2, 2015 | — |
| UPLOAD | Letter from the SEC | Feb 26, 2015 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2015 | — |
| UPLOAD | Letter from the SEC | Jan 23, 2015 | — |
| DRS/A | Filing | Jan 13, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 31, 2014 | — |
| DRS | Filing | Dec 4, 2014 | — |
| D | Filing | Mar 4, 2014 | — |
Showing 64 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SMMT (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Miami, FL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1599298
- Former names
- Summit Therapeutics plc (until Sep 17, 2020); Summit Corp plc (until Jan 30, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.